1077 related articles for article (PubMed ID: 28524659)
21. Natural Products as Chemopreventive Agents by Potential Inhibition of the Kinase Domain in ErbB Receptors.
Olivero-Acosta M; Maldonado-Rojas W; Olivero-Verbel J
Molecules; 2017 Feb; 22(2):. PubMed ID: 28218686
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and SAR studies of bis-chromenone derivatives for anti-proliferative activity against human cancer cells.
Venkateswararao E; Sharma VK; Manickam M; Yun J; Jung SH
Bioorg Med Chem Lett; 2014 Nov; 24(22):5256-9. PubMed ID: 25442319
[TBL] [Abstract][Full Text] [Related]
23. Design, Synthesis, and Biological Evaluation of Novel 1,3,4-Thiadiazole Derivatives as Potential Antitumor Agents against Chronic Myelogenous Leukemia: Striking Effect of Nitrothiazole Moiety.
Altıntop MD; Ciftci HI; Radwan MO; Sever B; Kaplancıklı ZA; Ali TFS; Koga R; Fujita M; Otsuka M; Özdemir A
Molecules; 2017 Dec; 23(1):. PubMed ID: 29280989
[TBL] [Abstract][Full Text] [Related]
24. Identification of novel Plasmodium falciparum PI4KB inhibitors as potential anti-malarial drugs: Homology modeling, molecular docking and molecular dynamics simulations.
Ibrahim MAA; Abdelrahman AHM; Hassan AMA
Comput Biol Chem; 2019 Jun; 80():79-89. PubMed ID: 30928871
[TBL] [Abstract][Full Text] [Related]
25. Novel p-Functionalized Chromen-4-on-3-yl Chalcones Bearing Astonishing Boronic Acid Moiety as MDM2 Inhibitor: Synthesis, Cytotoxic Evaluation and Simulation Studies.
Bhatia RK; Singh L; Garg R; Kaur M; Yadav M; Madan J; Kancherla S; Pissurlenkar RRS; Coutinho EC
Med Chem; 2020; 16(2):212-228. PubMed ID: 31146672
[TBL] [Abstract][Full Text] [Related]
26. Determination of the Apoptotic Effect and Molecular Docking of Benzamide Derivative XT5 in K562 Cells.
Ozkan T; Hekmatshoar Y; Ertan-Bolelli T; Hidayat AN; Beksac M; Aki-Yalcin E; Yalcin I; Sunguroglu A
Anticancer Agents Med Chem; 2018; 18(11):1521-1530. PubMed ID: 29298654
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, biological evaluation and molecular docking studies of novel 3-aryl-4-anilino-2H-chromen-2-one derivatives targeting ERα as anti-breast cancer agents.
Luo G; Chen M; Lyu W; Zhao R; Xu Q; You Q; Xiang H
Bioorg Med Chem Lett; 2017 Jun; 27(12):2668-2673. PubMed ID: 28460819
[TBL] [Abstract][Full Text] [Related]
28. In silico study directed towards identification of novel high-affinity inhibitors targeting an oncogenic protein: BRD4-BD1.
Tumdam R; Kumar A; Subbarao N; Balaji BS
SAR QSAR Environ Res; 2018 Dec; 29(12):975-996. PubMed ID: 30411639
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, molecular docking and inhibition studies of novel 3-N-aryl substituted-2-heteroarylchromones targeting microtubule affinity regulating kinase 4 inhibitors.
Parveen I; Khan P; Ali S; Hassan MI; Ahmed N
Eur J Med Chem; 2018 Nov; 159():166-177. PubMed ID: 30290280
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and antitumor activity of novel dithiocarbamate substituted chromones.
Huang W; Ding Y; Miao Y; Liu MZ; Li Y; Yang GF
Eur J Med Chem; 2009 Sep; 44(9):3687-96. PubMed ID: 19410339
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of Palladium(II) Complexes via Michael Addition: Antiproliferative Effects through ROS-Mediated Mitochondrial Apoptosis and Docking with SARS-CoV-2.
Haribabu J; Srividya S; Mahendiran D; Gayathri D; Venkatramu V; Bhuvanesh N; Karvembu R
Inorg Chem; 2020 Dec; 59(23):17109-17122. PubMed ID: 33231439
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and molecular docking study of new benzofuran and furo[3,2-g]chromone-based cytotoxic agents against breast cancer and p38α MAP kinase inhibitors.
Amin KM; Syam YM; Anwar MM; Ali HI; Abdel-Ghani TM; Serry AM
Bioorg Chem; 2018 Feb; 76():487-500. PubMed ID: 29310080
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of anticancer and antiobesity activity of 1-ethoxy carbonyl-3,5-bis (3'-indolyl methylene)-4-pyperidone analogs.
Buduma K; Chinde S; Dommati AK; Sharma P; Shukla A; Srinivas KVNS; Arigari NK; Khan F; Tiwari AK; Grover P; Jonnala KK
Bioorg Med Chem Lett; 2016 Mar; 26(6):1633-1638. PubMed ID: 26873414
[TBL] [Abstract][Full Text] [Related]
34. Targeting protein tyrosine phosphatase to unravel possible inhibitors for Streptococcus pneumoniae using molecular docking, molecular dynamics simulations coupled with free energy calculations.
Zaman Z; Khan S; Nouroz F; Farooq U; Urooj A
Life Sci; 2021 Jan; 264():118621. PubMed ID: 33164832
[TBL] [Abstract][Full Text] [Related]
35. Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A (TRKA) Inhibitors: Synthesis, Anticancer Activities,
Alam MS; Lee DU
Med Chem; 2022; 19(1):47-63. PubMed ID: 35490310
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and anticancer activity of novel 4-morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine derivatives bearing chromone moiety.
Sun C; Chen C; Xu S; Wang J; Zhu Y; Kong D; Tao H; Jin M; Zheng P; Zhu W
Bioorg Med Chem; 2016 Aug; 24(16):3862-9. PubMed ID: 27353887
[TBL] [Abstract][Full Text] [Related]
37. Novel carbapenem chalcone derivatives: synthesis, cytotoxicity and molecular docking studies.
Kommidi DR; Pagadala R; Rana S; Singh P; Shintre SA; Koorbanally NA; Jonnalagadda SB; Moodley B
Org Biomol Chem; 2015 Apr; 13(14):4344-50. PubMed ID: 25767041
[TBL] [Abstract][Full Text] [Related]
38. DNA-binding affinity, cytotoxicity, apoptosis, cell cycle inhibition and molecular docking studies of a new stilbene derivative.
Mehdipour M; Dehghan G; Yekta R; Hanifeh Ahagh M; Mahdavi M; Ghasemi Z; Fathi Z
Nucleosides Nucleotides Nucleic Acids; 2019; 38(2):101-118. PubMed ID: 30931800
[TBL] [Abstract][Full Text] [Related]
39. Molecular docking and dynamics studies of 4-anilino quinazolines for epidermal growth factor receptor tyrosine kinase to find potent inhibitor.
Muthuvel SK; Elumalai E; K G; K H
J Recept Signal Transduct Res; 2018; 38(5-6):475-483. PubMed ID: 31038021
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, Biological Activities and Docking Studies of Novel 4-(Arylaminomethyl)benzamide Derivatives as Potential Tyrosine Kinase Inhibitors.
Kalinichenko E; Faryna A; Kondrateva V; Vlasova A; Shevchenko V; Melnik A; Avdoshko O; Belko A
Molecules; 2019 Sep; 24(19):. PubMed ID: 31574962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
